2023/12 - Final USD(K$) | %Chg (Compare to Final) | 2022/12 USD(K$) | 2021/12 USD(K$) | 2020/12 USD(K$) | 2019/12 USD(K$) | |
Insurance Revenue | -- | -- | -- | -- | -- | -- |
Interest Income | -- | -- | -- | -- | -- | -- |
Turnover | -- | -- | -- | -- | -- | -- |
Gross Premium Income | 9,371,000 | 9.615% | 8,549,000 | 24,217,000 | 42,521,000 | 45,064,000 |
Net Premium Income | 9,200,000 | 8.953% | 8,444,000 | 22,373,000 | 10,312,000 | 43,481,000 |
Investment Income/(Loss) | 9,739,000 | -- | (29,313,000) | 3,486,000 | 44,991,000 | 49,555,000 |
Net Realised Gains/(Losses) on Assets | -- | -- | -- | -- | -- | -- |
Net Fair Value Gains / (Losses) on Assets | -- | -- | -- | -- | -- | -- |
Other Income/(Loss) | 369,000 | -98.676% | 27,866,000 | 641,000 | 670,000 | 700,000 |
Total Revenues | 19,308,000 | 175.947% | 6,997,000 | 26,500,000 | 55,973,000 | 93,736,000 |
Insurance Service Expenses | -- | -- | -- | -- | -- | -- |
Net Expenses from Reinsurance Contracts | -- | -- | -- | -- | -- | -- |
Net Finance (Expenses)/Income from Insurance Contracts | -- | -- | -- | -- | -- | -- |
Net Finance (Expenses)/Income from Reinsurance Contracts | -- | -- | -- | -- | -- | -- |
Net Impairment Loss | -- | -- | -- | -- | -- | -- |
Other Expenses | (16,945,000) | 128.031% | (7,431,000) | (23,834,000) | (54,071,000) | (91,846,000) |
Other Non-operating Items | -- | -- | -- | -- | -- | -- |
Share of results of Associates & JCEs | (91,000) | 7.059% | (85,000) | 352,000 | 517,000 | 397,000 |
Profit / (Loss) before Taxation | 2,272,000 | -- | (519,000) | 3,018,000 | 2,419,000 | 2,287,000 |
Taxation | (560,000) | 17.155% | (478,000) | (804,000) | (234,000) | (334,000) |
Profit / (Loss) for Discontinued Operations | -- | -- | -- | (5,027,000) | -- | (1,161,000) |
Non-controlling Interests | (11,000) | 10.000% | (10,000) | 771,000 | (67,000) | (9,000) |
Others | -- | -- | -- | -- | -- | -- |
Profit/ (Loss) Attributable to Shareholders | 1,701,000 | -- | (1,007,000) | (2,042,000) | 2,118,000 | 783,000 |
2023/12 - Final USD(K$) | %Chg (Compare to Final) | 2022/12 USD(K$) | 2021/12 USD(K$) | 2020/12 USD(K$) | 2019/12 USD(K$) | |
Depreciation & Amortisation | -- | -- | -- | 830,000 | 383,000 | 0 |
Directors' Emoluments | -- | -- | 16,818 | 17,492 | 18,285 | 29,998 |
2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
EPS (cts) | 62.100 | -- | -36.800 | -77.700 | 81.600 | 30.300 |
DPS (cts) | 20.470 | -- | 18.780 | 17.230 | 16.100 | 46.260 |
Dividend Payout Ratio (%) | 32.963% | -- | -- | -- | 19.730% | 152.673% |
Cash flow per share ($) | 0.304 | -- | 0.394 | (0.055) | 0.757 | (0.028) |
NBV per share ($) | 6.473 | -- | 6.085 | 6.222 | 8.001 | 7.488 |
Remarks: | Real time quote last updated: 23/08/2024 18:00 |
Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
Profit / (Loss) Attributable to Shareholders (K$) | USD 1,701,000 |
%Change | -- |
EPS / (LPS) | USD 0.621 |
NBV Per Share ($) | USD 6.473 |